Cirtuvivint
2-(4-methylpiperazin-1-yl)-N-[6-(1-methylpyrazol-4-yl)isoquinolin-3-yl]pyridine-4-carboxamide
Molecular Identity
Cirtuvivint
2-(4-methylpiperazin-1-yl)-N-[6-(1-methylpyrazol-4-yl)isoquinolin-3-yl]pyridine-4-carboxamide
PubChem CID: 132056570
2D Structure
Properties
C24H25N7O
Molecular Formula
427.50
Molecular Weight
g/mol
427.2121
Exact Mass
Da
2.4
XLogP
Drug-like (Lipinski: < 5)
79.2
TPSA
Good oral absorption (< 140 A²)
1
H-Bond Donors
6
H-Bond Acceptors
640
Complexity
SMILES
Canonical SMILES
SMILES: CN1CCN(CC1)C2=NC=CC(=C2)C(=O)NC3=NC=C4C=CC(=CC4=C3)C5=CN(N=C5)CIsomeric SMILES
SMILES: CN1CCN(CC1)C2=NC=CC(=C2)C(=O)NC3=NC=C4C=CC(=CC4=C3)C5=CN(N=C5)CSynonyms(20)
Cirtuvivint2143917-62-6Cirtuvivint [INN]7T1PY32ZPHUNII-7T1PY32ZPH2-(4-methylpiperazin-1-yl)-N-[6-(1-methylpyrazol-4-yl)isoquinolin-3-yl]pyridine-4-carboxamide4-Pyridinecarboxamide, 2-(4-methyl-1-piperazinyl)-N-(6-(1-methyl-1H-pyrazol-4-yl)-3-isoquinolinyl)-example 545 [WO2020150552]example 545 (WO2020150552)2-(4-methylpiperazin-1-yl)-N-(6-(1-methylpyrazol-4-yl)isoquinolin-3-yl)pyridine-4-carboxamide4-Pyridinecarboxamide, 2-(4-methyl-1-piperazinyl)-N-[6-(1-methyl-1H-pyrazol-4-yl)-3-isoquinolinyl]-RefChem:126361CDC-like kinase inhibitor of the Wnt PathwaySM08502N-(6-(1-Methyl-1H-pyrazol-4-yl)isoquinolin-3-yl)-2-(4-methylpiperazin-1-yl)isonicotinamide
Data from PubChem (NCBI)
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Drug Network
Trials and conditions connected to Cirtuvivint
Loading drug network...